Tournigand, C <br/><br/>
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).  [electronic resource] 

 -  Cancer  Mar 1997 
 - 1094-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(19970315)79:6<1094::aid-cncr6>3.0.co;2-g  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Colorectal Neoplasms--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Survival Analysis